Overview

A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment

Status:
Withdrawn
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Comparison of safety and efficacy of immunosuppressive regiments using tacrolimus from EMS and Prograf® in post renal transplanted patients.
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Immunosuppressive Agents
Methylprednisolone
Mycophenolate mofetil
Mycophenolic Acid
Tacrolimus